Profile
Matt joined OUP in 2013 and focuses on investments in therapeutics, diagnostics, medical devices, and research tools.
He has been involved with OUP’s investment in several portfolio companies including Biohaven Pharma (NYSE: BHVN), Synthorx (acquired by Sanofi), Kura Oncology (NASDAQ: KURA), Spero Therapeutics (NASDAQ: SPRO), Cell Design Labs (acquired by Gilead), Arrakis Therapeutics, PMV Pharma (NASDAQ: PMVP), Aerovate Therapeutics (NASDAQ: AVTE), Sana Biotechnology (NASDAQ: SANA), and others.
Currently, Matt sits on the board of Coho Therapeutics and IMMvention Therapeutix and holds board observer seats at Arrakis Therapeutics and Faraday Pharma.
Prior to joining OUP, Matt was a strategy consultant with L.E.K.
Consulting serving clients in biopharma, diagnostics, research tools, healthcare, and private equity.
Engagements included strategy development, market assessment, commercialization support, portfolio development, acquisition target identification, and diligence / transaction support.
As a Ph.D.
student at the University of Pennsylvania Matt conducted research on the antibody response to a novel protein-based poxvirus vaccine and advised several startups while working with the Penn Biotech Group.
Matt holds a Ph.D.
in Cell and Molecular Biology from The University of Pennsylvania, and a B.S.
in Microbiology from The Pennsylvania State University.
Matt resides in Gladwyne, PA with his wife Jenna and their two children.
Matthew Cohen active positions
| Companies | Position | Start |
|---|---|---|
OUP Management Co. LLC
OUP Management Co. LLC Investment ManagersFinance Osage Partners invests in companies located across the globe. The firm focuses on companies operating across a broad range of sectors. It provides financing for pre-seed, seed, early, late and growth stage capital requirements with an investment size of USD 1 - 20 million. The firm acts as a lead or co-lead investor. | Private Equity Investor | 2018-12-31 |
Former positions of Matthew Cohen
| Companies | Position | End |
|---|---|---|
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Consultant / Advisor | 2012-12-30 |
| SPERO THERAPEUTICS, INC. | Director/Board Member | - |
Training of Matthew Cohen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OUP Management Co. LLC
OUP Management Co. LLC Investment ManagersFinance Osage Partners invests in companies located across the globe. The firm focuses on companies operating across a broad range of sectors. It provides financing for pre-seed, seed, early, late and growth stage capital requirements with an investment size of USD 1 - 20 million. The firm acts as a lead or co-lead investor. | Finance |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
- Stock Market
- Insiders
- Matthew Cohen
















